Filter Results:
(130)
Show Results For
- All HBS Web
(130)
- People (1)
- News (57)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
Show Results For
- All HBS Web
(130)
- People (1)
- News (57)
- Research (57)
- Events (1)
- Multimedia (5)
- Faculty Publications (30)
- 18 Jul 2018
- Research & Ideas
No More General Tso's? A Threat to 'Knowledge Recombination'
pharmaceutical companies, which had been flying in scientists from China and India who, like Cohly, brought knowledge of native herbs. Some pharma companies were able to earn exemptions from the H1-B limits. Choudhury and Kim used this... View Details
- 01 Mar 2007
- News
Daniel Vasella
years the growth rate of the vaccine industry will be between 15 and 20 percent, making it a very attractive industry. The margins are, again, not as high as in patented, branded products, but they still are quite attractive. Also, one of the reasons why big View Details
- 31 May 2011
- First Look
First Look: May 31
within domestic Chinese companies, so he has turned to global multinational pharma companies, for now. The purpose of the case is to help present and future managers at global multinationals who have responsibility for R&D strategy to... View Details
Keywords: Sean Silverthorne
- 02 Aug 2004
- Research & Ideas
Health Care Research and Prospects
that. The fourth piece was executive education. Two years ago we launched an executive education program specifically for future leaders in pharma and biotech. And we've run it for the second year in a row this year. It's a very... View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
brand over another based on their patients' requests? A recent study, Physicians Report on Patient Encounters Involving Direct to Consumer Advertising, focused on one aspect of pharma DCTA: What do physicians think about all of this? What... View Details
Keywords: by Manda Salls
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
M&A team decided to achieve this goal through targeted transactions or “precision M&A.” By 2014, after examining 20 or so possible deals, the company was in the process of negotiating a multibillion dollar asset swap with Glaxo-Smith Kline (GSK) that was... View Details
Keywords: Carmen Nobel
- 23 Jan 2019
- News
The Promise of Personalized Medicine
end of the day, it’s the people that give me hope, that they’re there for the right reasons. Pharma nowadays gets a lot of negative press at pricing and things like that. It’s tough to say, but I don’t think that’s characteristic of the... View Details
- 04 Apr 2019
- Cold Call Podcast
Can Mark Zuckerberg Rebuild Trust in Facebook?
they're getting great results because of leadership. I think it's time for Mark Zuckerberg and Sheryl Sandberg to step up to leadership. Industries do not do a good job of self-regulation, so we have regulatory bodies. We don’t let pharma... View Details
- 19 Aug 2024
- News
Quantum Leap
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Dan Morrell: Hi, this is Dan Morrell, host of Skydeck. Quantum computing has long been talked about as one of the next big things—the kind of technology, like AI, that will change everything. But to our... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Transformation at Eli Lilly & Co. (A) Faced with the imminent loss of 40% of its revenues due to patent expirations, pharma giant Eli Lilly sets out on a dramatic transformation process in 2009. The case considers how Lilly... View Details
Keywords: Sean Silverthorne
- 24 Jul 2018
- First Look
New Research and Ideas, July 24, 2018
pharma company founded by Darwazah’s father in 1978 and traces the evolution of its governance as a private family company, then as a publicly traded company listed on the London Stock Exchange in 2005, and finally as a member of the FTSE... View Details
Keywords: Dina Gerdeman
- 21 Jun 2011
- First Look
First Look: June 21
ecosystem. Purchase this note:http://cb.hbsp.harvard.edu/cb/product/911066-PDF-ENG Cipla 2011 Rohit Deshpandé, Sandra J. Sucher, and Laura WinigHarvard Business School Case 511-050 Dr. Yusuf Hamied, head of the Indian pharma and generics... View Details
Keywords: Sean Silverthorne
- 14 Aug 2018
- First Look
First Look at New Research and Ideas, August 14, 2018
gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed and is considering an initial public offering. In addition, several large View Details
Keywords: by Sean Silverthorne
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
School Case 415-013 Novartis Pharmaceuticals Corp: Redefining Success in the U.S. (A) Over the course of a tumultuous weekend in April 2010, André Wyss was put in charge of Novartis Pharmaceuticals Corporation (NPC), the U.S. sales and marketing subsidiary of Novartis... View Details
Keywords: Sean Silverthorne
- 29 Apr 2014
- First Look
First Look: April 29
Harvard Business School Case 413-096 Novartis: Leading a Global Enterprise Novartis, the world's leading health care company, was formed in 1996 out of a merger of two very different, mid-tier Switzerland-based pharma companies. The case... View Details
Keywords: Sean Silverthorne
- 24 Apr 2018
- First Look
First Look at New Research and Ideas, April 24, 2018
development through individual contracts, the comprehensive platform would be free to doctors and pharma alike and financed via an aggressive fundraising strategy and through the sale of the prescription data collected on the app. Barry... View Details
Keywords: Sean Silverthorne
- Web
Past Issues - Alumni
Ozempic How a game-changing drug is reshaping Novo Nordisk, disrupting the pharma industry, and setting up a once-in-a-generation windfall for philanthropy Complete Table of Contents September 2024 Next Level How Sarah Bond (MBA 2006) is... View Details
- Web
Print View - Course Catalog
entrepreneurship and will cover therapeutics, devices, diagnostics, and related service providers, data, tools and technologies. Example topics of exploration may include emerging opportunities in pharma & biotech, medical device &... View Details